TY  - JOUR
T1  - JEhovah's witnesses may not have identical outcomes with nontransfused non-witnesses after cardiac surgery—reply
AU  - Pattakos G, Koch CG, Blackstone EH
Y1  - 2013/02/11
N1  - 10.1001/jamainternmed.2013.2139
JO  - JAMA Internal Medicine
SP  - 248
EP  - 249
VL  - 173
IS  - 3
N2  - 
Indeed, our original analysis included a comparison of Witness patients propensity-score matched to 322 non-Witness patients who were not transfused. The journal requested that we remove this part of the analysis from the printed article, but some of the material is included in the supplementary online-only content (see eAppendices 1 and 2 and eFigures 1-3 in our original investigation1). Reoperation for bleeding was less (0.3% vs 3.7%; P = .003) in non-Witness nontransfused patients compared with Witness patients (Table). Intensive care unit and postoperative lengths of stay were also slightly shorter and less variable (P = .02). However, other complications and hospital mortality were similar (Table), as were predischarge hematocrit values (Witness vs non-Witness nontransfused patients, 31% [4.6%] vs 31% [4.6%] [P = .70]). Survival of Witness patients was 86%, 69%, 51%, and 34% at 5, 10, 15, and 20 years after surgery, respectively, vs 86%, 69%, 52%, and 38% among matched non-Witness nontransfused patients, respectively (P > . 40).

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.2139
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.2139
ER  -